: +103% Gains were driven by breakthroughs in cystic fibrosis treatments and robust revenue growth.

: Outside the S&P 500, some smaller biotech firms like Madrigal Pharmaceuticals posted astronomical gains exceeding 500% .

: +81% Like D.R. Horton, this homebuilder benefited from a strong construction cycle and record consumer confidence levels. Market Context and Trends

: Biotech and pharmaceutical companies like Vertex saw triple-digit returns due to clinical trial breakthroughs.

: +131% The maker of Invisalign clear aligners saw explosive growth as digital dentistry began replacing traditional metal braces.